ArticleAnalytical chemistry2026
Multimodal Raman and Fluorescence Lifetime Imaging: A New Analytical Approach for Resolving Timing-Dependent Metabolic Recovery in Endothelial Dysfunction.
Article in Analytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Endothelial dysfunction involves profound metabolic and biochemical disturbances that disrupt vascular homeostasis, yet temporal recovery patterns remain analytically underexplored. This study presents a high-content analytical platform integrating spontaneous Raman scattering, stimulated Raman scattering, coherent anti-Stokes Raman scattering, and fluorescence lifetime imaging microscopy to quantitatively map molecular alterations associated with endothelial dysfunction in vitro. The multimodal approach enables simultaneous assessment of lipid metabolism, biochemical composition, and cellular bioenergetics with subcellular spatial resolution. Distinct spectral biomarkers were identified, including diagnostic Raman bands at 701, 1748, 2884, and 3011 cm-1, complemented by nonspectral descriptors such as reduced cell volume and accelerated lipid droplet formation. Chemometric analysis utilizing principal component analysis, partial least-squares regression, and semiquantitative lipid profiling revealed a pronounced timing-dependent response to enalaprilat. Preventive treatment was found to preserve metabolic integrity, whereas post-treatment induced only partial restitution and generated a divergent metabolic trajectory. These findings demonstrate that early intervention leads to analytically distinguishable molecular states, underscoring the relevance of temporal profiling in endothelial diagnostics. By establishing a multimodal spectroscopic and chemometric framework, this work highlights the analytical power of integrative imaging for resolving subtle metabolic phenotypes and refining strategies for the objective evaluation of therapeutic efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.